Baby Powder Lawsuit with Johnson and Johnson featured image showing a yellow and black danger asbestos sign on a concrete wall

Baby Powder Asbestos Case: Johnson & Johnson Cannot Evade $186 Million Punitive Damage Award

This July, Judge Ana C. Viscomi of the New Jersey Superior Court rejected Johnson & Johnson’s motion to reduce or dismiss a $186 million combined punitive damage award, which had already been reduced from $750 million in February. In denying the baby powder case appeal, the judge called the company’s behavior “reprehensible”.   NJ Jury…

Details
How Will COVID-19 Affect My Personal Injury Claim In Southern Arizona featured image showing a woman with safety mask from coronavirus

How Will Covid-19 Affect My Personal Injury Claim in Southern Arizona?

COVID-19 has upended life worldwide. This includes the legal system in Southern Arizona, which has faced court closures and delays, as well as restrictions on visits to attorneys. Challenges in receiving prompt and thorough medical attention, along with staffing problems at insurance companies, have also impacted the speed with which personal injury claims are resolved.…

Details
Drug Labels Inadequate article featured image showing tons of orange pill bottles with white labels and caps

Drug Labels Inadequate

Product liability lawsuits may be filed against manufacturers when their drug labels are inadequate. Sometimes the U.S. Food and Drug Administration catches the error and sends a warning letter, demands a label change, or mandates a recall. Federal action is not necessary to initiate a claim, however. One need only demonstrate that harm was caused…

Details
Metformin Recall

Metformin Recalls Ordered Based on Cancer-Causing Impurities

There has been a recall of the widely-prescribed diabetes medication metformin by at least one drug maker due to high levels of a cancer-causing agent known as N-Nitrosodimethylamine (NDMA). The U.S. Food and Drug Administration (FDA) stated that it is in contact with five pharmaceutical manufacturers about recalling their extended-release versions of the popular diabetes drug. Laboratory…

Details